K. Hasegawa et al. / Tetrahedron 62 (2006) 1390–1401
1397
hexane/i-PrOHZ99:1, retention time: 20.7 min (major, S)
and 23.1 min (minor, R).
28.3, 24.5, 22.8, 21.9; LRMS (FAB) 267 (MCK); HRMS
(FAB) calcd for C11H20N2O3K 267.1111, found: 267.1097;
[a]2D3 K12.0 (c 1.0, CHCl3, 22% ee); HPLC: DAICEL
CHIRALPAK AD-H, 254 nm, flow rate 0.5 mL/min,
hexane/i-PrOHZ99:1, retention time: 22.3 min (minor)
and 23.9 min (major).
3.2.1. tert-Butyl 2-diazo-3-hydroxy-3-(4-methoxy-
phenyl)propionate (4b). Yellow oil; IR (neat) n: 3449,
2978, 2095, 1729, 1667 cmK1; 1H NMR (CDCl3, 400 MHz)
d: 1.50 (s, 9H), 2.97 (br s, 1H), 3.81 (s, 3H), 5.82 (d, 1H, JZ
2.0 Hz), 6.89–7.36 (m, 4H); 13C NMR (CDCl3, 100 MHz) d:
165.8, 159.4, 130.9, 127.0, 114.0, 82.0, 68.4, 55.2, 28.3;
LRMS (FAB) m/z: 317 (MCK); HRMS (FAB) calcd
for C14H18N2O4K 317.0904, found: 317.0875; HPLC:
DAICEL CHIRALCEL OD, 254 nm, flow rate 0.5 mL/
min, hexane/i-PrOHZ95:5, retention time: 20.8 and
24.2 min.
3.2.6. tert-Butyl 2-diazo-3-hydroxy-4-methylpentanoate
(4g). Yellow oil; IR (neat) n: 3448, 2966, 2090, 1669 cmK1
;
1H NMR (CDCl3, 400 MHz) d: 0.94 (d, 3H, JZ6.8 Hz),
1.06 (d, 3H, JZ6.8 Hz), 1.49 (s, 9H), 1.82–1.94 (m, 1H),
2.58 (br s, 1H), 4.23 (dd, 1H, JZ4.4, 8.0 Hz); 13C NMR
(CDCl3, 100 MHz) d: 166.1, 81.7, 72.3, 32.8, 28.3, 18.7,
18.6; LRMS (FAB) 253 (MCK); HRMS (FAB) calcd for
C10H18N2O3K 253.0955, found: 253.0935; [a]2D2 K10.3 (c
0.6, CHCl3, 42% ee); HPLC: DAICEL CHIRALPAK
AD-H, 254 nm, flow rate 0.5 mL/min, hexane/i-PrOHZ
99:1, retention time: 32.2 min (minor) and 38.3 min (major).
3.2.2. tert-Butyl 2-diazo-3-hydroxy-3-(4-trifluoromethyl-
phenyl)propionate (4c). Yellow oil; IR (neat) n: 3448,
2981, 2095, 1734, 1693 cmK1;1HNMR(CDCl3, 400 MHz)d:
1.50 (s, 9H), 3.04 (br s, 1H), 5.91 (d, 1H, JZ3.4 Hz), 7.55 (d,
2H, JZ8.4 Hz), 7.65 (d, 2H, JZ8.4 Hz); 13C NMR (CDCl3,
100 MHz)d: 165.5, 143.0, 130.3 (q, JZ32.1 Hz), 126.2,125.7
(q, JZ4.1 Hz), 124.0 (q, JZ271 Hz), 82.5, 68.3, 28.3; LRMS
(FAB) m/z: 355 (MCK); HRMS (FAB) calcd for
C14H15F3N2O3K 355.0672, found: 355.0657; [a]2D6 K21.7 (c
1.1, CHCl3, 73% ee); HPLC: DAICEL CHIRALCEL OD,
254 nm, flow rate 0.5 mL/min, hexane/i-PrOHZ97:3,
retention time: 14.2 min (major) and 16.1 min (minor).
3.2.7. tert-Butyl 2-diazo-3-hydroxy-3-cyclohexylpropio-
nate (4h). Yellow oil; IR (neat) n: 3440, 2927, 2088,
1
1666 cmK1; H NMR (CDCl3, 400 MHz) d: 0.97–1.30 (m,
5H), 1.48 (s, 9H), 1.52–1.79 (m, 5H), 2.02 (d, 1H, JZ
12.8 Hz), 2.38 (br s, 1H), 4.25 (dd, 1H, JZ5.2, 8.4 Hz); 13C
NMR (CDCl3, 100 MHz) d: 166.1, 81.6, 71.2, 42.0, 29.1,
29.0, 28.3, 26.1, 25.8, 25.6; LRMS (FAB) m/z: 293 (MCK);
HRMS (FAB) calcd for C13H22N2O3K 293.1268, found
293.1284; [a]1D9 K3.4 (c 0.9, CHCl3, 33% ee) HPLC:
DAICEL CHIRALCEL OJ, 254 nm, flow rate 0.5 mL/min,
hexane/i-PrOHZ99:1, retention time: 22.1 min (major) and
35.8 min (minor).
3.2.3. tert-Butyl 2-diazo-3-hydroxy-3-(1-naphthyl)-
propionate (4d). Yellow solid (racemate); mp: 94 8C
1
(hexane); IR (neat) n: 3435, 2979, 2094, 1685 cmK1; H
NMR (CDCl3, 400 MHz) d: 1.54 (s, 9H), 3.00 (br s, 1H),
6.59 (d, 1H JZ2.4 Hz), 7.49–7.56 (m, 3H), 7.82–7.96 (m,
4H); 13C NMR (CDCl3, 100 MHz) d: 165.7, 134.1, 133.5,
129.5, 128.8, 128.7, 126.5, 125.7, 125.2, 123.2, 122.5, 82.1,
66.1, 28.5; LRMS (FAB) m/z: 337 (MCK); HRMS (FAB)
calcd for C17H18N2O3K 337.0955, found: 337.0941. Anal.
Calcd for C17H18N2O3: C, 68.44; H, 6.08; N, 9.39. Found:
C, 68.30; H, 5.92; N, 9.51; optically active form
(yellow oil), [a]2D5 K68.0 (c 0.7, CHCl3, 79% ee); HPLC:
DAICEL CHIRALCEL OD, 254 nm, flow rate 0.5 mL/min,
hexane/i-PrOHZ97:3, retention time: 24.3 min (minor) and
37.4 min (major).
3.2.8. tert-Butyl 2-diazo-3-hydroxy-4,4-dimethylvalerate
(4i). Yellow solid; mp 58–61 8C; IR (KBr) n: 3469, 2960,
1
2103, 1647 cmK1; H NMR (CDCl3, 400 MHz) d: 0.97 (s,
9H), 1.47 (s, 9H), 2.75 (br s, 1H), 4.20 (s, 1H); 13C NMR
(CDCl3, 100 MHz) d: 166.4, 81.6, 73.7, 38.3, 28.3, 25.6;
LRMS (FAB) m/z 267 (MCK); HRMS (FAB) calcd for
C11H20N2O3K 267.1111, found: 267.1104. Anal. Calcd for
C11H20N2O3: C, 57.87; H, 8.83; N, 12.27. Found: C, 57.92;
H, 8.83; N, 12.51; [a]D24 K20.4 (c 1.1, CHCl3, 81% ee);
HPLC: DAICEL CHIRALPAK AD-H, 254 nm, flow rate
0.5 mL/min, hexane/i-PrOHZ99:1, retention time:
25.7 min (minor) and 27.4 min (major).
3.2.4. tert-Butyl 2-diazo-3-hydroxy-5-phenylpentanoate
(4e). Yellow oil; IR (neat) n: 3422, 3026, 2930, 2091,
3.2.9. tert-Butyl 2-diazo-3-hydroxy-3-(4-tert butyl-
phenyl)propionate (4k). Yellow oil; IR (neat) n: 3467,
2965, 2093, 1732, 1687 cmK1; 1H NMR (CDCl3, 400 MHz)
d: 1.31 (s, 9H), 1.50 (s, 9H), 2.86 (br s, 1H), 5.83 (d, 1H, JZ
3.6 Hz), 7.34 (d, 2H, JZ8.0 Hz), 7.40 (d, 2H, JZ8.0 Hz);
13C NMR (CDCl3, 100 MHz) d: 165.8, 151.1, 136.0, 125.5,
125.4, 81.9, 68.5, 34.5, 31.2, 28.3; LRMS (FAB) m/z: 343
(MCK); HRMS (FAB) calcd for C17H24N2O3K 343.1424,
found: 343.1432; [a]2D6 K6.6 (c 0.9, CHCl3, 32% ee);
HPLC: DAICEL CHIRALCEL OD, 254 nm, flow rate
0.5 mL/min, hexane/i-PrOHZ97:3, retention time:
13.3 min (major) and 17.3 min (minor).
1
1685 cmK1; H NMR (CDCl3, 400 MHz) d: 1.48 (s, 9H),
1.84–1.93 (m, 1H), 1.99–2.08 (m, 1H), 2.57 (br s, 1H),
2.67–2.75 (m, 1H), 2.79–2.86 (m, 1H), 4.61–4.65 (m, 1H),
7.19–7.31 (m, 5H); 13C NMR (CDCl3, 100 MHz) d: 165.9,
140.9, 128.4, 128.3, 125.9, 81.8, 65.7, 35.6, 31.8, 28.2;
LRMS (FAB) m/z: 315 (MCK); HRMS (FAB) calcd for
C15H20N2O3K 315.1111, found: 315.1100; [a]2D3 K5.68 (c
0.3, CHCl3, 33% ee); HPLC: DAICEL CHIRALCEL OD-
H, 254 nm, flow rate 0.5 mL/min, hexane/i-PrOHZ95:5,
retention time: 16.7 min (major) and 19.0 min (minor).
3.2.5. tert-Butyl 2-diazo-3-hydroxy-5-methylhexanoate
(4f). Yellow oil; IR (neat) n: 3443, 2958, 2871, 2089,
3.2.10. tert-Butyl 2-diazo-3-hydroxy-3-(2-naphthyl)pro-
pionate (4l). Yellow oil; IR (neat) n: 3432, 2978, 2095,
1
1693 cmK1; H NMR (CDCl3, 400 MHz) d: 0.95 (d, 6H,
1
JZ6.4 Hz), 1.33–1.41 (m, 1H), 1.49 (s, 9H), 1.57–1.67 (m,
1H), 1.73–1.83 (m, 1H), 2.47 (br s, 1H), 4.70–4.75 (m, 1H);
13C NMR (CDCl3, 100 MHz) d: 166.0, 81.7, 64.7, 42.6,
1667 cmK1; H NMR (CDCl3, 400 MHz) d: 1.51 (s, 9H),
3.21 (br s, 1H), 6.03 (d, 1H, JZ2.4 Hz), 7.45–7.54 (m, 3H),
7.82–7.86 (m, 3H), 7.94 (s, 1H); 13C NMR (CDCl3,